APG
FBIO icon

Abacus Planning Group’s Fortress Biotech FBIO Stock Holding History

Abacus Planning Group’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.5K Hold
14,534
– – 0.01% 258
2026
Q1 		$40.5K Hold
14,534
– – 0.01% 263
2025
Q4 		$53.2K Hold
14,534
– – 0.01% 264
2025
Q3 		$53.7K Buy
+14,534
New +$36.7K 0.01% 257

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Abacus Planning Group's FBIO Position: Q2 2026 in Review

Abacus Planning Group held its Fortress Biotech (FBIO) position steady in Q2 2026 at 14,534 shares worth $44.5K. The position accounts for 0.01% of the portfolio, ranked #258.

Abacus Planning Group first reported a position in FBIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $53.7K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Abacus Planning Group held 14,534 shares of Fortress Biotech worth $44.5K as of Q2 2026.
  • Abacus Planning Group left its Fortress Biotech share count unchanged in Q2 2026.
  • Fortress Biotech made up 0.01% of Abacus Planning Group's portfolio in Q2 2026, its #258 holding.
  • Abacus Planning Group first reported a position in Fortress Biotech in Q3 2025 and has held it in 4 quarters since.
  • Abacus Planning Group's Fortress Biotech position peaked at $53.7K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.